This week, James is joined by Dr Toby Basey-Fisher, CEO & Founder of Entia, an oncology service provider supporting more effective cancer care by predicting and preventing treatment side effects. Having seen family members struggle with the challenges of poorly personalised cancer therapy, Toby founded Entia to change this. He received his PhD in Biomedical Physics from Imperial College London where he also holds an honorary lectureship. Toby has served as a board member at BIVDA and is a Blavatnik Enterprise Fellow of the Royal Academy of Engineering. He has overseen the growth of Entia from a university spin-out to an established market leader in oncology remote patient monitoring.
Learn more: <a href="https://www.entia.co/">https://www.entia.co/</a>
Apply to be a guest: <a href="https://www.thehealthtechpodcast.com/">www.thehealthtechpodcast.com</a>
Subscribe to Healthtech Pigeon 🐦: <a href="https://www.healthtechpigeon.com/">www.healthtechpigeon.com</a>
Get in touch with James: <a href="https://www.jamessomauroo.com/">www.jamessomauroo.com</a>
Learn more about SomX for your healthtech company at <a href="https://somx.health/">somx.health</a>

James Somauroo

#359 Changing the Model of Cancer Care with Dr Toby Basey-Fisher, CEO of Entia

This week, James is joined by Dr Toby Basey-Fisher, CEO & Founder of Entia, an oncology service provider supporting more effective cancer care by predicting and preventing treatment side effects. Having seen family members struggle with the challenges of poorly personalised cancer therapy, Toby founded Entia to change this. He received his PhD in Biomedical [&hellip;]